To access this element change to forms mode OFF

Grant Award View - GA217899

INTER-EWING -1 - International clinical research program to improve...

Contact Details

Department of Health

:
1800020103

:

GA ID:
GA217899
Agency:
Department of Health and Aged Care
Approval Date:
6-Dec-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Feb-2022 to 31-Jan-2027
Value (AUD):
$998,608.80 (GST inclusive where applicable)

One-off/Ad hoc:
No
Aggregate Grant Award:
No

PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
INTER-EWING -1 - International clinical research program to improve outcomes in newly diagnosed Ewing Sarcoma patients - Trial 1.
Purpose:
Ewing sarcoma (ES) is a rare cancer, which has a dismal survival rate once it has spread (30%) demonstrating an urgent need to improve outcomes.
INTER-EWING-1 (a phase III international trial) will investigate the impact of three interventions on survival for all newly diagnosed ES patients:
1. Adding a novel agent to standard chemotherapy
2. Optimising radiotherapy doses
3. Adding extra chemotherapy at the end of treatment.
It will open in Australia, New Zealand, United Kingdom and Europe.

GO ID:
GO Title:
MRFF 2021 Rare Cancers Rare Diseases Unmet Need General - Grant Opportunity
Internal Reference ID:
2021/MRF2015073
Selection Process:
Targeted or Restricted Competitive

Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property

Grant Recipient Details

Recipient Name:
Monash University
Recipient ABN:
12 377 614 012

Grant Recipient Location

Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA

Grant Delivery Location

State/Territory:
NSW, VIC, SA, WA, QLD, TAS, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED KINGDOM

Contact Details

Department of Health

:
1800020103

: